Regulatory & Audience
Who each country is speaking to — patient, HCP, caregiver — and where regulatory review stands
AE-reporting link present
9 / 13
MLR items in review
3
MLR items blocked
2
MLR items expired
1
Audience content coverage
0-100 · higher is better| Market | Patient | HCP | Caregiver | AE link |
|---|---|---|---|---|
Latvia grindeks.lv | 78 | 62 | 55 | Present |
Lithuania grindex.lt | 82 | 68 | 60 | Present |
Estonia grindeks.ee | 52 | 41 | 34 | Present |
Poland grindex.pl | 88 | 74 | 66 | Present |
Germany grindeks.de | 74 | 71 | 58 | Present |
Netherlands grindeks.nl | 22 | 18 | 12 | Present |
Denmark grindeks.dk | 71 | 58 | 51 | Present |
United Kingdom grindeks.co.uk | 68 | 74 | 55 | Present |
Australia grindeks.com.au | 54 | 47 | 38 | Missing |
Greece grindeks.gr | 41 | 32 | 24 | Present |
Moldova grindeks.md | 38 | 26 | 21 | Missing |
Azerbaijan grindeks.az | 24 | 14 | 8 | Missing |
Georgia grindeks.ge | 22 | 12 | 7 | Missing |
Medical-Legal-Regulatory (MLR) review
Lightweight workflow — full MLR when new comms lead landsKapsikam ZVA warning update (patient leaflet)
ZVA notice served 26 Jun. Agency ETA 48h.
Viprosal B SmPC rev. 2024-05 rollout
Approved copy, blocked on agency deploy.
AU AE-reporting module (TGA)
Regulatory exposure — 3 pages non-compliant.
Mildronāts HCP gate copy refresh
Signed off 20 Jun.
Nexovit caregiver FAQ (EU pack)
Sulfargin patient safety block (all EU pages)
Content valid until Feb 2026 — must be re-approved.
Rekord indication copy (CIS batch)
No local owner assigned — pending Nellija's team ramp-up.
Loperamīds pediatric warning